Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup

Autor: Bruno, W., Dalmasso, B., Barile, M., Andreotti, V., Elefanti, L., Colombino, M., Vanni, I., Allavena, E., Barbero, F., Passoni, E., Merelli, B., Pellegrini, S., Morgese, F., Danesi, R., Calò, V., Bazan, V., D’Elia, A.V., Molica, C., Gensini, F., Sala, E., Uliana, V., Soma, P.F., Genuardi, M., Ballestrero, A., Spagnolo, F., Tanda, E., Queirolo, P., Mandalà, M., Stanganelli, I., Palmieri, G., Menin, C., Pastorino, L., Ghiorzo, P.

Publikováno v: In ESMO Open August 2022 7(4)

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management

Autor: Berardi R, Morgese F, Rinaldi S, Torniai M, Mentrasti G, Scortichini L, Giampieri R

Publikováno v: Cancer Management and Research, Vol Volume 12, Pp 9363-9374 (2020)

Rossana Berardi, Francesca Morgese, Silvia Rinaldi, Mariangela Torniai, Giulia Mentrasti, Laura Scortichini, Riccardo Giampieri Clinica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, An

Externí odkaz: https://doaj.org/article/12182f5d3cd34344a212c3dbae6b72cb

Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.

Autor: Pecci F; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Cantini L; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Fortrea, Inc., Durham, NC, USA., Cognigni V; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Perrone F; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Mazzaschi G; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Agostinelli V; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Mentrasti G; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Favari E; Department of Food and Drug, University of Parma, Parma, Italy., Maffezzoli M; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Cortellini A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Rossi F; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Chiariotti R; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Venanzi FM; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Lo Russo G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Galli G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Proto C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ganzinelli M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tronconi F; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Morgese F; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Campolucci C; SOD Medicina di Laboratorio, Azienda Ospedaliera Universitaria delle Marche, Ancona, Italy., Moretti M; SOD Medicina di Laboratorio, Azienda Ospedaliera Universitaria delle Marche, Ancona, Italy., Vignini A; Department of Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy., Tiseo M; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Minari R; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Rocchi MLB; Biomolecular Sciences Department, University of Urbino, Urbino, Italy., Buti S; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Berardi R; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.

Publikováno v: The oncologist [Oncologist] 2024 Mar 04; Vol. 29 (3), pp. e372-e381.

Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel

Autor: Spada F., Bossi P., Caraco C., Sileni V. C., Dei Tos A. P., Fazio N., Grignani G., Maio M., Quaglino P., Queirolo P., Ascierto P. A., Antonini Cappellini G. C., Antonuzzo L., Badalamenti G., Barberis M., Bassetto F., Berardi R., Berruti A., Bongiovanni A., Bonomo P., Borgognoni L., Borzillo V., Bruder F., Campana D., Consoli F., Cordova A., Depenni R., Di Giacomo A. M., Fabbrocini G., Fargnoli M. C., Ferraresi V., Ferrau F., Fierro M. T., Gatti M., Gelsomino F., Giuffrida D., Graziano P., Gregorelli C., Guida M., Massi D., Mazzarotto R., Milesi L., Minisini A. M., Morgese F., Muto P., Palmieri G., Patuzzo R., Pellacani G., Picciotto F., Pigozzo J., Pimpinelli N., Poletti P., Repetto L., Rinaldi G., Rubegni P., Rubino G., Spagnolo F., Tagliaferri L., Tanda E., Tronconi M. C., Tucci M., Valente M., Vincenzi B., Zalaudek I.

Merkel cell carcinoma (MCC) is a rare and highly aggressive cutaneous neuroendocrine carcinoma. The MCC incidence rate has rapidly grown over the last years, with Italy showing the highest increase among European countries. This malignancy has been t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c388ac03c96e2f4867b5fc18f1e64dbe
http://hdl.handle.net/11577/3451638

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.

Autor: Rubatto M; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy. Electronic address: rubattomarco@gmail.it., Fava P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy., Stanganelli I; Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy., Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy., Pigozzo J; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Ridolfi L; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy., Trojaniello C; Department of Melanoma and Cancer Immunotherapy, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Bersanelli M; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Garutti M; CRO Aviano National Cancer Institute IRCCS, 33081 Aviano, Italy., Indini A; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., De Risi I; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., De Tursi M; Department of Medical, Oral and Biotechnological Sciences, Gabriele d'Annunzio University of Chieti and Pescara, Chieti, Italy., Merelli B; Unit of Medical Oncology, Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Piazza OMS 1, 24100 Bergamo, Italy., Morgese F; Clinica Oncologica, Università Politecnica delle Marche, AOU Ospedali Riuniti Di Ancona, Ancona, Italy., Occelli M; Department of Medicine, Clinical Oncology and Translational Research, Azienda Ospedaliera Santa Croce and Carle University Teaching Hospital, Cuneo, Italy., Cappellini GCA; UOC Oncologia Interpresidio, Ospedale Sandro Pertini, ASL Roma 2, Roma, Italy., Poletto S; Istituto di Candiolo, FPO - IRCCS, Candiolo, Italy; Department of Oncology, University of Turin, Torino, Italy., Fedele D; Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, Italy., Brugnara S; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Frisinghelli M; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Formisano L; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy., Conca R; Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero, Vulture, Italy., Tucci M; Department of Biomedical Sciences and Clinical Oncology, University of Bari 'Aldo Moro', Section of Internal Medicine and Oncology, P.za Giulio Cesare, 11, 70124 Bari, Italy., Russillo M; Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy., Ceroni L; University of Turin, Turin, Italy., Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy., Targato G; Department of Medical Oncology, Academic Hospital of Udine, Italy., Strippoli S; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jul; Vol. 187, pp. 25-35. Date of Electronic Publication: 2023 Mar 23.